These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19664668)

  • 1. Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease).
    Kay GW; Verbeek MM; Furlong JM; Willemsen MA; Palmer DN
    Neurochem Int; 2009 Dec; 55(8):783-8. PubMed ID: 19664668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic investigation of CLN6 neuronal ceroid lipofuscinosis in affected South Hampshire sheep.
    Pears MR; Salek RM; Palmer DN; Kay GW; Mortishire-Smith RJ; Griffin JL
    J Neurosci Res; 2007 Nov; 85(15):3494-504. PubMed ID: 17510975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients.
    Brouns R; De Vil B; Cras P; De Surgeloose D; Mariën P; De Deyn PP
    Clin Chem; 2010 Mar; 56(3):451-8. PubMed ID: 19959621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and cerebrospinal fluid S100B, neuron-specific enolase, and total tau protein in acute encephalopathy with biphasic seizures and late reduced diffusion: a diagnostic validity.
    Shiihara T; Miyake T; Izumi S; Watanabe M; Kamayachi K; Kodama K; Nabetani M; Ikemiyagi M; Yamaguchi Y; Sawaura N
    Pediatr Int; 2012 Feb; 54(1):52-5. PubMed ID: 21883688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients.
    Lamers KJ; Vos P; Verbeek MM; Rosmalen F; van Geel WJ; van Engelen BG
    Brain Res Bull; 2003 Aug; 61(3):261-4. PubMed ID: 12909296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum- and CSF-concentrations of brain specific proteins in hydrocephalus.
    Beems T; Simons KS; Van Geel WJ; De Reus HP; Vos PE; Verbeek MM
    Acta Neurochir (Wien); 2003 Jan; 145(1):37-43. PubMed ID: 12545260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A variant form of late infantile neuronal ceroid lipofuscinosis (CLN5) is not an allelic form of Batten (Spielmeyer-Vogt-Sjögren, CLN3) disease: exclusion of linkage to the CLN3 region of chromosome 16.
    Williams R; Santavuori P; Peltonen L; Gardiner RM; Järvelä I
    Genomics; 1994 Mar; 20(2):289-90. PubMed ID: 8020979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones.
    Steiner J; Bielau H; Bernstein HG; Bogerts B; Wunderlich MT
    J Neurol Neurosurg Psychiatry; 2006 Nov; 77(11):1284-7. PubMed ID: 17043297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A missense mutation (c.184C>T) in ovine CLN6 causes neuronal ceroid lipofuscinosis in Merino sheep whereas affected South Hampshire sheep have reduced levels of CLN6 mRNA.
    Tammen I; Houweling PJ; Frugier T; Mitchell NL; Kay GW; Cavanagh JA; Cook RW; Raadsma HW; Palmer DN
    Biochim Biophys Acta; 2006 Oct; 1762(10):898-905. PubMed ID: 17046213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of a lysosomal protease deficient in classical late infantile neuronal ceroid lipofuscinosis (LINCL) and development of an enzyme-based assay for diagnosis and exclusion of LINCL in human specimens and animal models.
    Sohar I; Sleat DE; Jadot M; Lobel P
    J Neurochem; 1999 Aug; 73(2):700-11. PubMed ID: 10428067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Brain and Cerebrospinal Fluid from Mouse Models of the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Changes in the Lysosomal Proteome.
    Sleat DE; Wiseman JA; El-Banna M; Zheng H; Zhao C; Soherwardy A; Moore DF; Lobel P
    Mol Cell Proteomics; 2019 Nov; 18(11):2244-2261. PubMed ID: 31501224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of the neuronal ceroid lipofuscinoses.
    Mole S; Gardiner M
    Epilepsia; 1999; 40 Suppl 3():29-32. PubMed ID: 10446748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3- and CLN2-deficient neurons.
    Dhar S; Bitting RL; Rylova SN; Jansen PJ; Lockhart E; Koeberl DD; Amalfitano A; Boustany RM
    Ann Neurol; 2002 Apr; 51(4):448-66. PubMed ID: 11921051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease.
    Shematorova EK; Shpakovski GV
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid markers in neurological disorders.
    Massaro AR; Scivoletto G; Tonali P
    Ital J Neurol Sci; 1990 Dec; 11(6):537-47. PubMed ID: 1707039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Untargeted Metabolite Profiling of Cerebrospinal Fluid Uncovers Biomarkers for Severity of Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2, Batten Disease).
    Sindelar M; Dyke JP; Deeb RS; Sondhi D; Kaminsky SM; Kosofsky BE; Ballon DJ; Crystal RG; Gross SS
    Sci Rep; 2018 Oct; 8(1):15229. PubMed ID: 30323181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic oral administration of minocycline to sheep with ovine CLN6 neuronal ceroid lipofuscinosis maintains pharmacological concentrations in the brain but does not suppress neuroinflammation or disease progression.
    Kay GW; Palmer DN
    J Neuroinflammation; 2013 Jul; 10():97. PubMed ID: 23899308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease.
    Jesse S; Steinacker P; Cepek L; von Arnim CA; Tumani H; Lehnert S; Kretzschmar HA; Baier M; Otto M
    J Alzheimers Dis; 2009; 17(3):541-51. PubMed ID: 19433893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing variants in sheep CLN3, the gene underlying juvenile neuronal ceroid lipofuscinosis.
    Oswald MJ; Palmer DN; Damak S
    Mol Genet Metab; 1999 Jun; 67(2):169-75. PubMed ID: 10356317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease.
    Green AJ; Thompson EJ; Stewart GE; Zeidler M; McKenzie JM; MacLeod MA; Ironside JW; Will RG; Knight RS
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):744-8. PubMed ID: 11385008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.